Convergence Insufficiency Treatment Trial Attention and Reading Trial (CITT-ART)

收敛不足治疗试验注意力和阅读试验（CITT-ART）

• 批准号: 8842638
• 负责人: SUSANNA M TAMKINS
• 金额: $ 11.84万
• 依托单位: UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-05-01 至 2019-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8842638
• 关键词: Adherence; Advertisements; Aftercare; Attention; Attention deficit hyperactivity disorder; Behavior; Caring; Child; Child Care; Clinical; Clinical Trials; Clinical Trials Design; Cognitive; Communities; Confidentiality; Consent; Controlled Clinical Trials; Convergence Insufficiency; Data; Data Coordinating Center; Development; Documentation; Educational Curriculum; Eligibility Determination; Enrollment; Ensure; Equipment; Ethics; Evaluation; Eye; Future; Good Clinical Practice; Helsinki Declaration; Home environment; Human Resources; Individual; Institutes; Investigation; Lead; Long-Term Effects; Manuals; Masks; Measures; Methods; Ohio; Optometry; Outcome; Outcome Measure; Parents; Participant; Patients; Pennsylvania; Performance; Physicians; Placebo Control; Placebos; Policies; Principal Investigator; Privacy; Procedures; Protocols documentation; Psychological reinforcement; Psychologist; Publications; Qualifying; Quality Control; Randomized; Randomized Clinical Trials; Reading; Records; Recruitment Activity; Reporting; Schedule; Site; Surveys; Symptoms; Testing; Training and Education; Underrepresented Minority; Universities; Vision Disorders; Visit; achievement test; aged; base; college; design; experience; follow-up; human subject protection; interest; listening comprehension; meetings; primary outcome; reading ability; reading comprehension; secondary outcome; teacher; treatment effect; treatment program; treatment trial

DESCRIPTION (provided by applicant): This proposal Is for the University of Miami Bascom Palmer Eye Institute [BPEIJ to serve as a clinical center for the Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART), a multicenter randomized, placebo controlled, clinical trial designed to evaluate the effects of treatment for symptomatic convergence insufficiency (Cl) on measures of reading performance and attention in children. In this trial, 324 children aged 9 to <14 years with symptomatic Cl will be randomly assigned to 16 weeks of: 1) office-based vergence/ accommodative therapy with home-reinforcement or 2) office-based placebo therapy. After 16 weeks of treatment, the primary outcome measures of reading comprehension (Wechsler Individual Achievement test [WIAT-III]) reading comprehension subtest score and attention (Strengths and Weaknesses of ADHD Symptoms & Normal Behavior Scale [SWAN]) will be assessed by examiners masked to treatment group. The Gates MacGlnitie-4 test, which uses a format similar to curriculum-based evaluation done in classrooms, will provide a secondary measure of reading comprehension. Reading fluency, another test of attention, the Cl Symptom Survey, and clinical measures of Cl (i.e., the near point of convergence, and positive fusional vergence al near) are other secondary outcome measures; also included are assessments of key reading and cognitive components that impact reading comprehension including pseudo word decoding, word reading, and listening comprehension. Long-term effects on reading achievement and attention are assessed 1-year post treatment. This application documents our site's ability to recruit at least 36 subjects and o retain them for 1 year after completion of treatment. Documentation is provided that our site has the appropriate personnel, equipment, and facilities to conduct the study in accordance with the CITT-ART Manual of Procedures (MOP). Complete details of the study rationale, design, and methods are contained in the Manual of Procedures (submitted with the Study Chair and Data Coordinating Center [DCC] applications). In addition to our center, there are 8 other optometric or ophthalmologic centers, the Study Chair at the Pennsylvania College of Optometry at Salus University, and the DCC at The Ohio State University Optometry Coordinating Center. Symptomatic Cl is a common vision disorder in children that is commonly associated with symptoms while reading (e.g. loss of place, loss of concentration, frequent re-reading, reading slowly, and trouble remembering what was read). However, the effect of Cl treatment on reading and attention is unknown. The results of the proposed study will lead to a better understanding of these relationships and have important implications for educators, psychologists, and physicians who care for children with reading and attention problems. The findings will guide hypothesis development for future scientific investigations in children with vision disorders.

描述（由申请人提供）：本提案是为迈阿密大学巴斯科姆帕尔默眼科研究所[BPEIJ]作为会聚功能不全治疗试验-注意力和阅读试验（cit - art）的临床中心，这是一项多中心随机、安慰剂对照的临床试验，旨在评估治疗症状性会聚功能不全（Cl）对儿童阅读表现和注意力的影响。在这项试验中，324名患有症状性Cl的9至14岁儿童将被随机分配到16周：1)以办公室为基础的融合/调节治疗与家庭强化或2)以办公室为基础的安慰剂治疗。治疗16周后，由主考官对治疗组的阅读理解（韦氏个人成就测试[WIAT-III]）、阅读理解子测试得分和注意力（ADHD症状与正常行为量表[SWAN]）进行评估。Gates MacGlnitie-4测试采用了与课堂上基于课程的评估类似的形式，它将为阅读理解提供第二个衡量标准。阅读流畅性、另一项注意力测试、Cl症状调查和Cl的临床测量（即近收敛点和正融合收敛点）是其他次要结果测量；还包括对影响阅读理解的关键阅读和认知成分的评估，包括伪单词解码、单词阅读和听力理解。治疗后1年评估对阅读成绩和注意力的长期影响。本申请证明我们的研究中心有能力招募至少36名受试者，并在治疗完成后保留他们1年。提供的文件表明，我们的现场有适当的人员、设备和设施来按照cit - art程序手册（MOP）进行研究。研究基本原理、设计和方法的完整细节包含在程序手册中（与研究主席和数据协调中心[DCC]申请一起提交）。除了我们的中心，还有其他8个验光或眼科中心，Salus大学宾夕法尼亚验光学院的研究主席，以及俄亥俄州立大学验光协调中心的DCC。症状性Cl是一种常见的儿童视力障碍，通常与阅读时的症状有关（例如，迷失位置、注意力不集中、频繁重复阅读、阅读速度慢、难以记住所读内容）。然而，氯离子治疗对阅读和注意力的影响尚不清楚。这项研究的结果将有助于更好地理解这些关系，并对那些关心有阅读和注意力问题的儿童的教育工作者、心理学家和医生具有重要意义。这一发现将指导未来对视力障碍儿童进行科学研究的假设发展。